Literature DB >> 32240440

Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma.

Chuantao Zhang1, Jianxiang Liu2, Zhiyi Han3, Xiang Cui3, Deti Peng3, Yufeng Xing4.   

Abstract

BACKGROUND: Increase of the Ca2+-activated chloride channel TMEM16A is contribute to tumorigenesis. However, the expression level of TMEM16A and its underlying molecular mechanism for TMEM16Apromotingliver carcinogenesis is remains unknown.
METHODS: In the present study, the expression of TMEM16A in hepatocellular carcinoma (HCC) tissues were measured by quantitative reverse-transcription polymerase chain reaction (qRT-PCR), Western blot and immunohistochemical. Cell proliferation was detected using CCK-8, EdU staining and colony formation methods. Flow cytometry was carried out for detecting cell cycle distribution and apoptosis rate. Migration and invasion abilities were analyzed using transwell and wound healing assay. Western blot method was performed to analyze protein expression.
RESULTS: Here, we found TMEM16A was significantly increased in HCC tissues, and a higher TMEM16A expression levels were detected in larger tumor size, higher tumor grade, with distant metastasis and poor differentiation. Moreover, overexpression of TMEM16A promoted HCC growth, migration and invasion, and suppressed apoptosis in vitro and in vivo. Knockdown of TMEM16A inhibited HCC growth, migration and invasion, and induced apoptosis in vitro and in vivo. Furthermore, TMEM16A regulated PI3K/AKT-MAKP signaling pathway.
CONCLUSION: Our data indicate that TMEM16A may represent a novel biomarker of HCC and may be a potential therapeutic target for diagnosis and therapy.

Entities:  

Keywords:  Cell proliferation; HCC; PI3K/AKT-MAKP; TMEM16A; Tumorigenesis

Mesh:

Substances:

Year:  2020        PMID: 32240440     DOI: 10.1007/s10147-020-01653-6

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  25 in total

Review 1.  Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.

Authors:  Daniela Sia; Augusto Villanueva; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2016-12-30       Impact factor: 22.682

2.  Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor-κB signaling pathway.

Authors:  Jun Liu; Yu Liu; Yingang Ren; Li Kang; Lihua Zhang
Journal:  Mol Med Rep       Date:  2014-01-08       Impact factor: 2.952

3.  Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.

Authors:  Adrian Britschgi; Anke Bill; Heike Brinkhaus; Christopher Rothwell; Ieuan Clay; Stephan Duss; Michael Rebhan; Pichai Raman; Chantale T Guy; Kristie Wetzel; Elizabeth George; M Oana Popa; Sarah Lilley; Hedaythul Choudhury; Martin Gosling; Louis Wang; Stephanie Fitzgerald; Jason Borawski; Jonathan Baffoe; Mark Labow; L Alex Gaither; Mohamed Bentires-Alj
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

Review 4.  Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment.

Authors:  Masatoshi Kudo; Franco Trevisani; Ghassan K Abou-Alfa; Lorenza Rimassa
Journal:  Liver Cancer       Date:  2016-11-29       Impact factor: 11.740

5.  Studies on expression and function of the TMEM16A calcium-activated chloride channel.

Authors:  Fen Huang; Jason R Rock; Brian D Harfe; Tong Cheng; Xiaozhu Huang; Yuh Nung Jan; Lily Yeh Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-24       Impact factor: 11.205

6.  Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells.

Authors:  Yujie Sui; Meiyan Sun; Fei Wu; Longfei Yang; Weihua Di; Guizhen Zhang; Lili Zhong; Zhiming Ma; Jinhao Zheng; Xuedong Fang; Tonghui Ma
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

7.  ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC).

Authors:  D R P Sauter; I Novak; S F Pedersen; E H Larsen; E K Hoffmann
Journal:  Pflugers Arch       Date:  2014-08-28       Impact factor: 3.657

8.  Suppression of 14-3-3γ-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells.

Authors:  Young-Sun Lee; Jae Kwang Lee; Yeonju Bae; Bok-Soon Lee; Eunju Kim; Chang-Hoon Cho; Kanghyun Ryoo; Jiyun Yoo; Chul-Ho Kim; Gwan-Su Yi; Seok-Geun Lee; C Justin Lee; Sang Soo Kang; Eun Mi Hwang; Jae-Yong Park
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

9.  Knockdown of TMEM16A suppressed MAPK and inhibited cell proliferation and migration in hepatocellular carcinoma.

Authors:  Liang Deng; Jihong Yang; Hongwu Chen; Bo Ma; Kangming Pan; Caikun Su; Fengfeng Xu; Jihong Zhang
Journal:  Onco Targets Ther       Date:  2016-01-14       Impact factor: 4.147

10.  The long noncoding RNA TUG1 acts as a competing endogenous RNA to regulate the Hedgehog pathway by targeting miR-132 in hepatocellular carcinoma.

Authors:  Jingjing Li; Qinghui Zhang; Xiaoming Fan; Wenhui Mo; Weiqi Dai; Jiao Feng; Liwei Wu; Tong Liu; Sainan Li; Shizan Xu; Wenwen Wang; Xiya Lu; Qiang Yu; Kan Chen; Yujing Xia; Jie Lu; Yingqun Zhou; Ling Xu; Chuanyong Guo
Journal:  Oncotarget       Date:  2017-07-26
View more
  7 in total

Review 1.  Role of ANO1 in tumors and tumor immunity.

Authors:  Haini Li; Zongxue Yu; Haiyan Wang; Ning Wang; Xueguo Sun; Shengmei Yang; Xu Hua; Zongtao Liu
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-26       Impact factor: 4.322

2.  Diagnostic and prognostic values of upregulated SPC25 in patients with hepatocellular carcinoma.

Authors:  Xiaolin Yang; Hongzhi Sun; Ying Song; Li Yang; Haibo Liu
Journal:  PeerJ       Date:  2020-07-16       Impact factor: 2.984

Review 3.  Chloride Channels and Transporters: Roles beyond Classical Cellular Homeostatic pH or Ion Balance in Cancers.

Authors:  Hyeong Jae Kim; Peter Chang-Whan Lee; Jeong Hee Hong
Journal:  Cancers (Basel)       Date:  2022-02-09       Impact factor: 6.639

4.  TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.

Authors:  Shuai Guo; Xue Bai; Sai Shi; Yawen Deng; Xianjiang Kang; Hailong An
Journal:  Int J Mol Sci       Date:  2021-10-10       Impact factor: 5.923

5.  ANO1: More Than Just Calcium-Activated Chloride Channel in Cancer.

Authors:  Saisai Guo; Linna Zhang; Na Li
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

Review 6.  DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Vincenzo Fiorentino; Patrizia Straccia; Pietro Tralongo; Teresa Musarra; Francesco Pierconti; Maurizio Martini; Guido Fadda; Esther Diana Rossi; Luigi Maria Larocca
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

Review 7.  The Ca2+-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?

Authors:  Yani Liu; Zongtao Liu; KeWei Wang
Journal:  Acta Pharm Sin B       Date:  2020-12-09       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.